Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the ...

Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer ...

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...

Life-saving antibiotics that could treat severe infections in babies and children aren't accessible due to a lack of data ...

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergised impacts of worldwide clinical ...

U.S. clinical trials for ALS do not include enough non-white patients and women to reflect the disease's real-world prevalence, per a study.

As a doctor working in genomic research, I know that we lack vital data for Black people and many other groups. Here's how we ...